cetylpyridinium chloride anhydrous has been researched along with vildagliptin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dole, WP; He, YL; Howard, D; Leon, S; Ligueros-Saylan, M; Riviere, GJ; Rosenberg, M; Sabo, R; Sunkara, G | 1 |
| Dole, WP; He, YL; Ligueros-Saylan, M; Serra, D; Wang, Y; Zhang, Y | 1 |
2 trial(s) available for cetylpyridinium chloride anhydrous and vildagliptin
| Article | Year |
|---|---|
Effect of the novel oral dipeptidyl peptidase IV inhibitor vildagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
Topics: Adamantane; Administration, Oral; Adult; Anticoagulants; Cross-Over Studies; Dipeptidyl-Peptidase IV Inhibitors; Drug Administration Schedule; Drug Interactions; Female; Health; Humans; Hypoglycemic Agents; Male; Nitriles; Pyrrolidines; Vildagliptin; Warfarin | 2007 |
Thorough QT study of the effects of vildagliptin, a dipeptidyl peptidase IV inhibitor, on cardiac repolarization and conduction in healthy volunteers.
Topics: Adamantane; Adolescent; Adult; Cardiovascular Physiological Phenomena; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Health; Healthy Volunteers; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Nitriles; Placebos; Pyrrolidines; Vildagliptin; Young Adult | 2011 |